FDA Inspection
Lupin Ltd.Lupin Ltd. – FDA Inspection, Apr 3, 2015
Record Details
This FDA Inspection record concerns Lupin Ltd., with an inspection on April 3, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lupin Ltd.
- Inspection Date
- April 3, 2015
- Product Type
- Drugs
View Company Profile
ID · 8ce1a427-1a6c-4832-8f38-15a864edab4d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 919852
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lupin Ltd.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| March 15, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 15, 2019 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| July 28, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Lupin Ltd.
- FDA Inspection 1280668 - 2025-09-05
- FDA Inspection 1235550 - 2024-03-15
- FDA Inspection 1121188 - 2020-02-14
- FDA Inspection 1090546 - 2019-05-15
- FDA Inspection 1024531 - 2017-07-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.